What's breaking now, across thousands of outlets.
The latest installment in BioPharma Dive’s data visualization series features a closer look at Novo's stock performance and the recent run of fundraising success for AI drug discovery startups.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Weiter steigende Anleiherenditen, neue Entwicklungen im Nahen Osten und neue Firmendeals bewegen am Freitag die Börse. In Washington endet derweil das Treffen zwischen Trump und Xi.
Pullback or reversal? Here's what the charts suggest for BTC.
One of the UK’s biggest car hire businesses has taken aim at government tax hikes after it plunged to a £43.2m loss. Europcar UK, which is backed by German carmaker VW, recorded a profit of £7m in…
Bernstein analysts suggest Wall Street isn’t properly modeling the extent to which gross margins, a profit metric, could take a hit due to the rising costs of smartphone components.
Bernstein analysts suggest Wall Street isn’t properly modeling the extent to which gross margins, a profit metric, could take a hit due to the rising costs of smartphone components.
